Identification of prostate cancer mRNA markers by averaged differential expression and their detection in biopsies, blood, and urine.

Identification of prostate cancer mRNA markers by averaged differential expression and their detection in biopsies, blood, and urine. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Identification of prostate cancer mRNA markers by averaged differential expression and their detection in biopsies, blood, and urine. Abstract Text:

V Uma Bai,Ahmed Kaseb,Sheela Tejwani,George W Divine,Evelyn R Barrack,Mani Menon,Arthur B Pardee,G Prem-Veer Reddy,

The advent of serum prostate-specific antigen (PSA) as a biomarker has enabled early detection of prostate cancer and, hence, improved clinical outcome. However, a low PSA is not a guarantee of disease-free status, and an elevated PSA is frequently associated with a negative biopsy. Therefore, our goal is to identify molecular markers that can detect prostate cancer with greater specificity in body fluids such as urine or blood. We used the RT-PCR differential display method to first identify mRNA transcripts differentially expressed in tumor vs. patient-matched nontumor prostate tissue. This analysis led to the identification of 44 mRNA transcripts that were expressed differentially in some but not all tumor specimens examined. To identify mRNA transcripts that are differentially expressed in most tumor specimens, we turned to differential display of pooled tissue samples, a technique we name averaged differential expression (ADE). We performed differential display of mRNA from patient-matched nontumor vs. tumor tissue, each pooled from 10 patients with various Gleason scores. Differentially expressed mRNA transcripts identified by ADE were fewer in number, but were expressed in a greater percentage of tumors (>75%) than those identified by differential display of mRNA from individual patient samples. Differential expression of these mRNA transcripts was also detected by RT-PCR in mRNA isolated from urine and blood samples of prostate cancer patients. Our findings demonstrate the principle that specific cDNA probes of frequently differentially expressed mRNA transcripts identified by ADE can be used for the detection of prostate cancer in urine and blood samples.

Identification of prostate cancer mRNA markers by averaged differential expression and their detection in biopsies, blood, and urine. Publishing Authors By Initials

VU Bai,A Kaseb,S Tejwani,GW Divine,ER Barrack,M Menon,AB Pardee,GP Reddy,

For similar biological factors: biological markers: tumor markers, biological research abstracts see: biological factors: biological markers: tumor markers, biological research

PUBMED ID PMID:

MEDLINE DATE:

Identification of prostate cancer mRNA markers by averaged differential expression and their detection in biopsies, blood, and urine. Journal Published:

PUBLICATION TYPE: Research Support, U.S. Gov't,

Journal: Proceedings of the National Academy of Sciences of

VOLUME: 104

Page Numbers: 2343-8

Journal Abbreviation: Proc. Natl. Acad. Sci. U.S.A.

ISSN: 0027-8424

DAY: 5

MONTH: 02

YEAR: 2007

Identification of prostate cancer mRNA markers by averaged differential expression and their detection in biopsies, blood, and urine. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7505876

Identification of prostate cancer mRNA markers by averaged differential expression and their detection in biopsies, blood, and urine. Keywords Mesh Terms:

KEYWORDS: Tumor Markers, Biological

MESH TERMS: urine

Chemical & Substance for Abstract: Identification of prostate cancer mRNA markers by averaged differential expression and their detection in biopsies, blood, and urine. Information

Substance Name: Tumor Markers, Biological

Registry Number: 0

Grant and Affiliation Information for Identification of prostate cancer mRNA markers by averaged differential expression and their detection in biopsies, blood, and urine.

AFFILIATION: Vattikuti Urology Institute, Henry Ford Health System, Detroit, MI 48202, USA.

Country: United States

AGENCY: United States NIDDK

GRANT: R01-DK57864

ACRONYM: DK

MEDLINETA: Proc Natl Acad Sci U S A

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Identification of prostate cancer mRNA markers by averaged differential expression and their detection in biopsies, blood, and urine Related Publications

• A JNK-independent signaling pathway regulates TNF alpha-stimulated, c-Jun-driven FRA-1 protooncogene transcription in pulmonary epithelial cells.
• Ablation of left ventricular epicardial outflow tract tachycardia from the distal great cardiac vein.
• Adenovirus mediated expression of human paraoxonase 2 protects against the development of atherosclerosis in apolipoprotein E-deficient mice.
• An efficient process for synthesis of 2'-O-methyl and 3'-O-methyl guanosine from 2-aminoadenosine using diazomethane and the catalyst stannous chloride.
• Calmodulin-androgen receptor (AR) interaction: calcium-dependent, calpain-mediated breakdown of AR in LNCaP prostate cancer cells.
• Compensation for spin-lock artifacts using an off-resonance rotary echo in T1rhooff-weighted imaging.
• Elevated serum kininogen in patients with Paget's disease of bone: a role in marrow stromal/preosteoblast cell proliferation.
• Exit-site care in peritoneal dialysis.
• Expanding the range of brominated Q1 analogues.
• Frontiers in musculoskeletal MRI: articular cartilage.
• Heads up on cerebral bleeds.
• Immunohistochemical study of monocyte chemoattractant protein-1 in the pancreas of NOD mice following cyclophosphamide administration and during spontaneous diabetes.
• In vivo measurement of plaque burden in a mouse model of Alzheimer's disease.
• Increased yield of high purity recombinant human interferon-gamma utilizing reversed phase column chromatography.
• Invariant chlorine isotopic signatures during microbial PCB reductive dechlorination.
• Lymphopenia-induced proliferation of donor T cells reduces their capacity for causing acute graft-versus-host disease.
• Mitochondrial oxidative damage in aging and Alzheimer's disease: implications for mitochondrially targeted antioxidant therapeutics.
• Pancreatic stem cells: differentiation options.
• Paraoxonase-2 deficiency aggravates atherosclerosis in mice despite lower apolipoprotein-B-containing lipoproteins: anti-atherogenic role for paraoxonase-2.
• Pharmacotherapy for secondary prevention of stroke.
• Presence of a surface-exposed loop facilitates trypsinization of particles of Sinsiro virus, a genogroup II.3 norovirus.
• Pterostilbene, an active constituent of blueberries, suppresses aberrant crypt foci formation in the azoxymethane-induced colon carcinogenesis model in rats.
• RANK ligand signaling modulates the matrix metalloproteinase-9 gene expression during osteoclast differentiation.
• Replitase: complete machinery for DNA synthesis.
• Robinow syndrome.
• Sexual abuse and sexual functioning in a chronic pelvic pain sample.
• Sodium and T1rho MRI for molecular and diagnostic imaging of articular cartilage.
• Subtypes of Ischemic Stroke in a Metropolitan City of South India (One year data from a hospital based stroke registry).
• Unruptured intracranial aneurysms : review of natural history and recommended management strategies.
• What is the most appropriate energy source for aortic cusp ablation? A comparison of standard RF, cooled-tip RF and cryothermal ablation.